The present invention relates to an activator of the calcineurin subunit A&bgr1 isofomi (CnA&bgr1) or of the C-terminal domain of the calcineurin subunit A&bgr1 isofomi (CnA&bgr1) for the production of a medicament for the modulation of myocardial growth without adversely affecting contractile function.